Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
27.70
-1.17 (-4.05%)
At close: Mar 27, 2026, 4:00 PM EDT
27.16
-0.54 (-1.95%)
After-hours: Mar 27, 2026, 7:15 PM EDT

Assembly Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
58.4538.3419.8452.4245.63
Short-Term Investments
189.6673.74110.4139.19101
Cash & Short-Term Investments
248.11112.08130.2591.61146.63
Cash Growth
121.37%-13.95%42.18%-37.52%-32.25%
Accounts Receivable
0.97-0.040.940.34
Other Current Assets
5.473.423.54.417.24
Total Current Assets
254.55115.5133.7996.97154.2
Net Property, Plant & Equipment
2.733.352.723.947.18
Long-Term Investments
----27.97
Other Long-Term Assets
0.310.310.310.891.7
Total Assets
257.59119.17136.82101.79191.06
Accounts Payable
1.170.590.462.492.66
Accrued Expenses
10.149.146.6310.4410.26
Current Portion of Leases
0.570.461.223.363.15
Unearned Revenue
36.937.6230.92--
Total Current Liabilities
48.7847.839.2316.316.07
Long-Term Leases
2.062.631.120.13.33
Other Long-Term Liabilities
-35.3855.382.732.73
Total Long-Term Liabilities
2.0638.0156.52.836.06
Total Liabilities
50.8485.8195.7319.1322.13
Common Stock
0.020.010.0100.05
Additional Paid-in Capital
1,039859.49826.92807.98800.73
Accumulated Other Comprehensive Income
-0.04-0.21-0.08-0.8-0.42
Retained Earnings
-832.05-825.93-785.75-724.52-631.43
Shareholders' Equity
206.7533.3641.182.66168.93
Total Liabilities & Equity
257.59119.17136.82101.79191.06
Total Debt
2.633.092.343.476.48
Net Cash (Debt)
245.48108.99127.9188.15140.15
Net Cash Growth
125.23%-14.79%45.11%-37.11%-32.06%
Net Cash Per Share
21.9018.1527.9421.8538.86
Book Value
206.7533.3641.182.66168.93
Book Value Per Share
18.445.568.9820.4946.84
Tangible Book Value
206.7533.3641.182.66168.93
Tangible Book Value Per Share
18.445.568.9820.4946.84
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q